Introduction
============

Myopia is the most common cause of visual impairment worldwide. Myopia is a condition in which parallel light passes through the eye and focuses in front of the retina. Myopia can be classified as common myopia with refractive error less than −6 diopters (D) and high myopia with refractive error equal or greater than −6 D. Myopia can sometimes be an accompanying symptom in other diseases. Thus, myopia can also be classified as non-syndromic myopia (if it occurs alone) and syndromic myopia (if it is an associated sign of another ocular or systemic disease). As common myopia is too common to be a sign of a specific disease, usually high myopia has been reported as a specific phenotype of a syndrome or other ocular or systemic diseases; thus, syndromic myopia usually means syndromic high myopia. Myopia may also be classified as physiologic myopia (usually low-grade myopia) and pathological myopia (mostly associated with degenerative changes in the retina). Sometimes, common or physiologic myopia in early childhood may develop as high myopia or pathological myopia in adult or older individuals. Most individuals with high myopia may not have pathological changes in the retina, especially in younger ages.

Genetic and environmental factors are well known components that contribute to the development of myopia. Common myopia is more likely to be a complex trait, resulting from the effects of genetic and environmental factors. High myopia may be transmitted as a complex trait (especially late-onset high myopia commonly seen in university students) or a Mendelian trait (such as most early-onset high myopia that is not related to extensive near work) \[[@r1]\]. Efforts to decipher the hereditary determinants of myopia began in the 1960s, and the important role of genetic factors has been implicated in several studies, including familial aggregation, pedigree analysis, twin studies, and population studies. Until now, many loci and genes associated with myopia have been identified with linkage analysis, association studies, whole exome sequencing, and experimental myopia studies. This paper reviews the genetic determinations of myopia and the molecular genetics of non-syndromic and syndromic myopia according to the different approaches.

2. Contribution of genetic factors to the development of human myopia
---------------------------------------------------------------------

### 2.1 Hereditability and familial aggregation of myopia

Familial aggregation has provided strong evidence to support the important role of genetic factors in causing the pathogenesis of myopia \[[@r2]-[@r6]\]. Studies on individuals with myopia from different populations have shown positive indications. For example, Yap et al. performed refraction examinations on 2,888 children in China to investigate the risks of passing myopia from parents to children \[[@r2]\]. This study showed that children with myopic parents tend to have a greater chance of developing myopia than those without myopic parents. Several subsequent studies also supported this finding. Ip et al. conducted a similar study on 2,353 children in Australia with a mean age of 7 years \[[@r4]\]. The results suggested that the prevalence of myopia increased statistically significantly with the number of myopic parents; the associated development risk rates are 7.6% for no myopic parents, 14.9% for one myopic parent, and 43.6% for two myopic parents. In addition, the recurrence risks of myopia among siblings with myopia are also higher than siblings without myopia. A report based on 6,497 inhabitants in Tehran, Iran, confirmed that the heritability of refractive error is 61%, and the ratio of sibling recurrence odds for myopia is 2.25--3.00 \[[@r6]\]. Apart from refraction status, the impacts of myopia in parental history on children's ocular growth were also observed. Lam et al. followed up with 7,560 children in China for 1 year and reported the effects of myopia in parental history, including eye size and growth. The change in annual axial length increased with the number of myopic parents: 0.20 mm, 0.26 mm, and 0.37 mm for children with no, one, and two myopic parents, respectively \[[@r3]\]. This line of evidence suggests that the genetic risks are higher in families with myopia.

### 2.2 Genetic transmission traits of myopia

Pedigree analysis is widely used in myopia and high myopia studies. High myopia is often found to be transmitted through families in Mendelian patterns, including autosomal dominant (AD), autosomal recessive (AR), and X-linked recessive (XL) inheritance. Based on linkage analysis, 18 myopia and high myopia loci have been discovered and documented in the Online Mendelian Inheritance in Man database ([OMIM](https://www.ncbi.nlm.nih.gov/omim/)), including nine high myopia loci in AD inheritance (*MYP2*: Gene ID 4658, OMIM [160700](https://www.ncbi.nlm.nih.gov/omim/?term=160700) \[[@r7]\], *MYP3*: Gene ID 8782, OMIM [603221](https://www.ncbi.nlm.nih.gov/omim/?term=603221) \[[@r8]\], *MYP5*: Gene ID 404682, OMIM [608474](https://www.ncbi.nlm.nih.gov/omim/?term=608474) \[[@r9]\], *MYP11*: Gene ID 594832, OMIM [609994](https://www.ncbi.nlm.nih.gov/omim/?term=609994) \[[@r10]\], *MYP12*: Gene ID 664780, OMIM [609995](https://www.ncbi.nlm.nih.gov/omim/?term=609995) \[[@r11]\], *MYP15*: Gene ID 100294716, OMIM [612717](https://www.ncbi.nlm.nih.gov/omim/?term=612717) \[[@r12]\], *MYP16*: Gene ID 100270641, OMIM [612554](https://www.ncbi.nlm.nih.gov/omim/?term=612554) \[[@r13]\], *MYP17*: Gene ID 100359401, OMIM [608367](https://www.ncbi.nlm.nih.gov/omim/?term=608367) \[[@r14]\], and *MYP19*: Gene ID 100653370, OMIM [613969](https://www.ncbi.nlm.nih.gov/omim/?term=613969) \[[@r15]\]), one high myopia locus in AR inheritance (*MYP18*, Gene ID 100359406, OMIM [255500](https://www.ncbi.nlm.nih.gov/omim/?term=255500) \[[@r16]\]), two XL recessive high myopia loci (*MYP1*: Gene ID 4657, OMIM [310460](https://www.ncbi.nlm.nih.gov/omim/?term=310460) \[[@r17]\] and *MYP13*: Gene ID 677764, OMIM [300613](https://www.ncbi.nlm.nih.gov/omim/?term=300613) \[[@r18]\]), and six myopia loci (*MYP6*: Gene ID 9997, OMIM [608908](https://www.ncbi.nlm.nih.gov/omim/?term=608908) \[[@r19]\], *MYP7*: Gene ID 553190, OMIM [609256](https://www.ncbi.nlm.nih.gov/omim/?term=609256) \[[@r20]\], *MYP8*: Gene ID 553192, OMIM [609257](https://www.ncbi.nlm.nih.gov/omim/?term=609257) \[[@r20]\], *MYP9*: Gene ID 553194, OMIM [609258](https://www.ncbi.nlm.nih.gov/omim/?term=609258) \[[@r20]\], *MYP10*: Gene ID 553195, OMIM [609259](https://www.ncbi.nlm.nih.gov/omim/?term=609259) \[[@r20]\], and *MYP14*: Gene ID 100359407, OMIM [610320](https://www.ncbi.nlm.nih.gov/omim/?term=609320) \[[@r21]\]). The identification of these 18 loci in the human genome through linkage studies not only indicates the contribution of genetic factors to myopia but also provides clues for further screening of candidate genes.

### 2.3 Twin study: Monozygotic twins have more similar refraction than dizygotic twins

A twin study is an ideal way to estimate the hereditary component of myopia. This study design provides cogent evidence for the important role of genetic factors in myopia. Monozygotic twins are identical in genetic material, while dizygotic twins share 50% of their genetic material. Therefore, monozygotic twins are considered to have more similarity in phenotype for genetic diseases. A comparison of similarity in refraction power between monozygotic and dizygotic twins can be used to evaluate the heritability of myopia. Karlsson et al. systemically reviewed a series of twin studies and found that 95% of monozygotic twins appear to have a similar refraction power, and only 29% of dizygotic twins have such similarity \[[@r22]\]. Subsequently, several large-scale twin studies from different countries confirmed this finding, and the heritability varied from 75% to 94% \[[@r23]-[@r25]\]. In addition, the impacts of genetic and environmental factors on myopia have been observed by analyzing refraction power in 1,152 monozygotic twins and 1,149 dizygotic twins: 77% of the difference in refraction power was explained by genetic components, while 7% of the difference was explained by environmental factors \[[@r26]\]. This result once again supports the importance of genetic factors in the development of myopia.

### 2.4 SNPs in myopia-related genes from population-based association studies

Population-based association studies include genome-wide association studies (GWASs) and case-control studies. Population-based association studies have identified that many single nucleotide polymorphisms (SNPs) are statistically significantly associated with myopia, suggesting the involvement of multiple gene effects. The traits used in an association study include spherical equivalent (SE), axial length, and corneal curvature. Although there are some controversial issues and arguments related to the results of association studies, some SNPs have been replicated and confirmed to be statistically significantly associated with myopia or high myopia in separate independent studies from different populations. The replication of significant SNPs is necessary before further analysis is conducted. Disease-associated SNPs would be more convincing if they could be replicated in different large-scale GWASs. For example, Kiefer et al. \[[@r27]\] and Verhoeven et al. \[[@r28]\] identified several significant associations of SNPs in 45,771 and 45,758 participants with myopia and refractive error, respectively. Twelve SNPs were discovered in these two different studies, which provided strong evidence that the 12 SNPs are statistically significantly associated with myopia. Association studies, similar to pedigree analysis, have indicated the importance of genetic factors in myopia and provided clues for discovering new causative genes.

3. Molecular genetic basis of non-syndromic myopia
--------------------------------------------------

The role of molecular genetics in myopia has been investigated mainly in population- and family-based studies. GWASs, as one of the major forms, have been widely used to identify associations between the characteristics of myopia (i.e., refraction, axial length, or corneal curvature) and genetic variants across the whole genome. Meanwhile, linkage analysis was traditionally applied in family-based studies to exploit linkage regions within families, especially for Mendelian high myopia. Aside from the approaches above, whole exome sequencing and experimental myopia studies have also been applied to reveal the molecular genetic basis of myopia. Overall, molecular genetic studies on myopia have identified numerous loci and genes, which are of great importance in implicating the mechanisms underlying myopia.

### 3.1 Linkage analysis of the genetic loci for myopia

Myopia is generally heterogeneous. Through linkage analysis of families with myopia and high myopia, about 18 loci have been identified. The details of these 18 loci were mentioned above and are listed in [Table 1](#t1){ref-type="table"}. The candidate genes inside the linkage intervals have been screened based on their potential functions involved in the development of myopia.

###### Loci identified by linkage studies.

  **Phenotype**        **Location**    **MIM number**   **Size(Mb)**   **Lod Score**   **Study poplution**   **Reference**
  -------------------- --------------- ---------------- -------------- --------------- --------------------- ------------------------------
  **adHM**                                                                                                    
  MYP2                 18p11.31        160,700          7.6-cM         9.59            USA                   (Young TL et al., 2001)
  MYP3                 12q21-q23       603,221          30.1-Cm        3.85            German/Italian        (Young TL et al., 1998)
  MYP5                 17q21-q22       608,474          7.71-cM        3.17            English/Canadian      (Paluru P et al., 2003)
  MYP11                4q22-q27        609,994          20.4-cM        3.11            Chinese               (Zhang Q et al., 2005)
  MYP12                2q37.1          609,995          9.1 cM         4.75            Northern European     (Paluru PC et al., 2005)
  MYP15                10q21.1         612,717          2.67 cM        3.22            Hutterite             (Nallasamy S, 2007)
  MYP16                5p15.33-p15.2   612,554          17.45Mb        4.81            Chinese               (Lam CY et al., 2008)
  MYP17                7p15            608,367          7.81 cM        NA              France                (Paget et al., 2008)
  MYP19                5p15.1-p13.3    613,969          14.14-Mb       3.71            Chinese               (Ma et al., 2010)
  **arHM**                                                                                                    
  MYP18                14q22.1-q24.2   255,500          25.23-Mb       2.19            Chinese               (Yang et al., 2009)
  **X-linked HM**                                                                                            
  MYP1                 Xq28            310,460          6.1cM          3.59            Chinese               (Guo et al., 2010)
  MYP13                Xq23-q27.2      300,613          25-cM          2.75            Chinese               (Zhang et al., 2006)
  **Complex myopia**                                                                                         
  MYP6                 22q12.3         608,908          4cM            3.54            Ashkenazi Jewish      (Stambolian et al., 2004)
  MYP7                 11p13           609,256          40cM           6.1             UK                    (Hammond et al., 2004)
  MYP8                 3q26            609,257          185cM          3.7             UK                    (Hammond et al., 2004)
  MYP9                 4q12 3.3        609,258          65cM           3.3             UK                    (Hammond et al., 2004)
  MYP10                8p23            609,259          NA             3.7             UK                    (Hammond et al., 2004)
  MYP14                1p36            610,320          49.1 Cm        9.5             Ashkenazi Jewish      (Wojciechowski et al., 2006)

Note: adHM, autosomal dominant high myopia; arHM, autosomal recessive high myopia; NA, not available

### 3.1.1 Susceptibility loci for common myopia

Common myopia is usually considered a complex trait because genetic and environmental factors contribute to the susceptibility risk. The genetic mapping of complex traits has identified six susceptibility loci for myopia. Among them, four loci (*MYP7*--*MYP10*) were identified in a genome-wide scan with a multipoint linkage analysis in 226 monozygotic and 280 dizygotic twins, using refraction as a quantitative trait ranging from −12.12 D to + 7.25 D \[[@r20]\]. In these four loci, *MYP10* was replicated in a GWAS with high myopia (rs189798) \[[@r29]\], and *MYP7* was replicated in another genome-wide scan in dizygotic twins \[[@r20],[@r30]\].

For two other loci, *MYP*6 and *MYP14*, *MYP6* was mapped in a genome-wide scan in 44 Ashkenazi Jewish families with mild to moderate myopia \[[@r19]\]. The scan was replicated in another genome-wide scan of 486 extended families with refractions ranging from −12.13 D to +8.38 D \[[@r31]\]. *MYP14* was identified in a genome-wide scan with multipoint regression-based quantitative trait locus (QTL) linkage in 49 Ashkenazi Jewish families (mean SE=−3.46 D ± 3.29 D) \[[@r21]\]. In a large international collaborative study of high myopia, *MYP14* (1p36.32) was replicated in a subset of 24 families from Denmark with a maximum logarithm (base 10) of odds (LOD) score of 1.8 at rs1870509 in a multipoint linkage analysis \[[@r32]\].

Candidate genes within these six myopia loci have been screened according to their related functions. *PAX6* (Gene ID: 5080, OMIM: [607108](https://www.ncbi.nlm.nih.gov/omim/?term=607108)), located in the *MYP7* locus, has been of great concern and research interest. *PAX6* is an important transcriptional regulator involved in the development of the eye \[[@r33]\] from the surface ectoderm to the cornea and the lens \[[@r34],[@r35]\] and from the neuroectoderm to the iris, ciliary body, and retina \[[@r36],[@r37]\]. Mutations in *PAX6* are associated with a wide range of abnormalities in humans, including aniridia, Peter's anomaly, microcornea, cataract, coloboma of the optic nerve, microphthalmia, and nystagmus \[[@r38]-[@r43]\]. Studies have reported an association between *PAX6* and high myopia \[[@r44]-[@r49]\], but these results are not consistent with other studies \[[@r50]-[@r52]\]. Therefore, *PAX6* should be evaluated with caution as a candidate gene for myopia. *MYP8*, *MYP9*, and *MYP10* have not been investigated yet as candidate genes.

### 3.1.2 Genetic loci and genes identified in families with high myopia

In genetic analysis of non-syndromic high myopia, 12 loci have been identified using linkage studies, as mentioned above ([Table 1](#t1){ref-type="table"}). These loci were frequently observed in families with Mendelian high myopia, characterized by onset in early childhood (≤7 years old) and monogenic inheritance. Several loci have been replicated or refined in independent families using the same approach.

Of these 12 loci, *MYP1*, located at Xq28, is a locus for non-syndromic and syndromic high myopia (the latter will be discussed in the section on syndromic myopia). In studies on non-syndromic high myopia, *MYP1* was mapped in a Chinese family \[[@r17]\] with high myopia, and the finding was replicated in two Indian families \[[@r53]\]. *MYP3* was revealed by Young et al. in a large German--Italian family \[[@r8]\] and was further replicated in at least four independent studies involving different populations \[[@r32],[@r54]-[@r56]\]. Moreover, a genome-wide scan in 254 families with high myopia also discovered the *MYP1*, *MYP3*, *MYP6*, *MYP11*, *MYP12*, and *MYP14* loci and identified a novel locus at chromosome 9q34.11 \[[@r32]\]. In addition, several loci have been replicated in association studies on myopia, including *MYP11*, *MYP15*, *MYP16*, and *MYP17*. However, compared with the high prevalence of high myopia in the general population, these 12 loci account for fewer than 5% of individuals with high myopia, suggesting that more loci and genes await to be identified.

Numerous candidate genes in these 12 loci have been screened in different kinds of studies, including direct sequencing, association analysis, and experimental animal analysis. Although several candidate genes or SNPs have been investigated frequently in association studies, inconsistent results were often noted. No mutations in candidate genes have been identified in mapped families using Sanger sequencing ([Table 2](#t2){ref-type="table"}) \[[@r10],[@r11],[@r13],[@r15],[@r17],[@r53],[@r57]-[@r59]\]. For example, *TGIF* (Gene ID 7050, OMIM [602630](https://www.ncbi.nlm.nih.gov/omim/?term=602630)), located in the *MYP2* locus, is expressed strongly in the sclera, retina, and optic nerve. *TGIF* is involved in the regulation of the transforming growth factor (TGF)-beta pathway \[[@r60]\], which has a close relationship with the development of myopia \[[@r61],[@r62]\]. However, screening mutations in *TGIF* among affected members in families mapped to *MYP2* did not identify any cosegregated mutations; no significant associations between SNPs in *TGIF* and high myopia were reported \[[@r3],[@r63],[@r64]\]. Although knockout of *LUM* (Gene ID 4060, OMIM [600616](https://www.ncbi.nlm.nih.gov/omim/?term=600616); located in *MYP3*) in mice showed a series of myopia-related phenotypes \[[@r65]\], Sanger sequencing of *LUM* in an *MYP3*-mapped family did not identify any mutations \[[@r57]\]. Other candidate genes within these loci are not listed here because of their undetermined relationship with myopia. The exact mutations among these genes need to be further studied. Especially with the method of whole exome sequencing, which fully screens all genes within linkage regions for mapped families, new genes are expected to be revealed in the future.

###### Candidate genes within linkage region were screened in mapped-families using Sanger sequencing.

  **Position**    **Locus**   **Genes**   **Reference**
  --------------- ----------- ----------- ---------------------------------------------
  2q37.1          MYP12       SAG         (Paluru et al., 2005)
  2q37.1          MYP12       DGKD        (Paluru et al., 2005)
  4q22-q27        MYP11       RRH         (Zhang et al., 2005)
  5p15.33-p15.2   MYP16       IRX2        (Lam et al., 2008)
  5p15.33-p15.2   MYP16       IRX1        (Lam et al., 2008)
  5p15.33-p15.2   MYP16       POLS        (Lam et al., 2008)
  5p15.33-p15.2   MYP16       CCT5        (Lam et al., 2008)
  5p15.33-p15.2   MYP16       LOC442129   (Lam et al., 2008)
  5p15.33-p15.2   MYP16       CTNND2      (Lam et al., 2008)
  5p13.3-p15.1    MYP19       CDH6        (Ma et al., 2010)
  5p13.3-p15.1    MYP19       CDH10       (Ma et al., 2010)
  5p13.3-p15.1    MYP19       CDH12       (Ma et al., 2010)
  5p13.3-p15.1    MYP19       PDZD2       (Ma et al., 2010)
  5p13.3-p15.1    MYP19       GOLPH3      (Ma et al., 2010)
  5p13.3-p15.1    MYP19       ZFR         (Ma et al., 2010)
  12q21-q23       MYP3        LUM         (Paluru et al., 2004)
  18p11.31        MYP2        TGIF        (Scavello et al., 2004; Young et al., 2004)
  18p11.31        MYP2        EMLIN-2     (Young et al., 2004)
  18p11.31        MYP2        MLCB        (Young et al., 2004)
  18p11.31        MYP2        CLUL1       (Young et al., 2004)
  Xq28            MYP1        GPR50       (Guo X et al., 2010)
  Xq28            MYP1        PRRG3       (Guo X et al., 2010)
  Xq28            MYP1        CNGA2       (Guo X et al., 2010)
  Xq28            MYP1        BGN         (Guo X et al., 2010)
  Xq28            MYP1        CTAG2       (Ratnamala et al., 2011)
  Xq28            MYP1        GAB3        (Ratnamala et al., 2011)
  Xq28            MYP1        MPP         (Ratnamala et al., 2011)
  Xq28            MYP1        F8Bver      (Ratnamala et al., 2011)
  Xq28            MYP1        FUNDC2      (Ratnamala et al., 2011)
  Xq28            MYP1        VBP1        (Ratnamala et al., 2011)
  Xq28            MYP1        RAB39B      (Ratnamala et al., 2011)
  Xq28            MYP1        CLIC2       (Ratnamala et al., 2011)
  Xq28            MYP1        TMLHE       (Ratnamala et al., 2011)
  Xq28            MYP1        SYBL        (Ratnamala et al., 2011)
  Xq28            MYP1        IL9R        (Ratnamala et al., 2011)
  Xq28            MYP1        SPRY3       (Ratnamala et al., 2011)
  Xq28            MYP1        CXYorf1     (Ratnamala et al., 2011)

### 3.2 Genetic association studies on myopia

To investigate the genetic factors for myopia in the general population, GWASs and a series of replications in follow-up association studies have identified numerous associations with myopia, although some are uncertain. A literature search was conducted in PubMed (until 11/18/2016) using the following terms: (association) and myopia/genetics, myopia and gene and association, and (association) and refractive errors/genetics. Only association studies related to myopia are included and reviewed in this section. There were some controversial issues in the GWASs and case-control association studies, such as the level of the test and the sample sizes. Thus, this part of the review mainly focuses on genetic loci that were detected by GWASs and met the significance standard of p\<5 × 10^−8^.

### 3.2.1 Evidence of associations between polymorphisms and common myopia

Thus far, around 82 loci for myopia have been examined in GWASs and case-control association studies using refractions between −0.50 D and −6.00 D as parameters (Appendix 1) \[[@r3],[@r27],[@r52],[@r66]-[@r94]\]. Of these 82 loci, 41 loci were identified by seven GWAS and GWAS meta-analyses (Appendix 1) that met the requirement of p\<5 × 10^−8^. An important principle for an association study is replication, replication, and replication. The 15q14 locus has been confirmed frequently in replication studies over the past few years ([Table 3](#t3){ref-type="table"}). Until now, about 20 association studies have aimed to test the relationship between the 15q14 locus and myopia in different populations, and only three showed no statistically significant association due to the small size of the samples. The SNP rs634990, reaching the greatest p value of 9.20 × 10^−23^, was identified by a GWAS meta-analysis in 55,177 samples in Caucasian and Asian populations. Known genes near the 15q14 locus include *GJD2* (OMIM [607058](https://www.ncbi.nlm.nih.gov/omim/?term=607058)), *ACTC1* (Gene ID 70, OMIM [102540](https://www.ncbi.nlm.nih.gov/omim/?term=102540)), *GOLGA8B* (Gene ID 440270, OMIM [609619](https://www.ncbi.nlm.nih.gov/omim/?term=609619)), *LPCAT4* (Gene ID 254531, OMIM [612039](https://www.ncbi.nlm.nih.gov/omim/?term=612039)), and *CHRM5* (Gene ID 1133, OMIM [118496](https://www.ncbi.nlm.nih.gov/omim/?term=118496)). Of these genes, *gap junction protein, delta 2* (*GJD2*), is located closest to the most significant SNP rs634900. *GJD2* was first screened in 47 individuals with refractive error, but no pathogenic variants were identified. Later in our previous study, a sequence analysis of *GJD2*, which had been detected in significant association with myopia in the 15q14 locus within the cohort, did not identify any causative variants. As for the other genes in the 15q14 locus, none have been reported in statistically significant association with myopia. Therefore, the mechanism underlying this significant p value needs to be studied further.

###### Summary of studies which identified the 15q14 locus.

  **Locus**   **Best SNP**   **Best p value**   **Population**               **First author, year**
  ----------- -------------- ------------------ ---------------------------- ------------------------
  15q14       rs634990       2.21E-14           Dutch                        Solouki, 2010
  15q14       rs634990       8.78E-07           Japanese                     Hayashi, 2011
  15q14       rs634990       9.20E-23           Caucasian and Asian          Verhoeven, 2012
  15q14       rs560764       6.40E-04           Caucasian                    Schache, 2013
  15q14       rs634990       8.81E-07           Chinese                      Jiao, 2012
  15q14       rs1357179      1.69E-03           Caucasian                    Simpson, 2013
  15q14       rs524952       5.60E-19           European                     Kiefer, 2013
  15q14       rs11073060     9.11E-11           Multi-Ethnic                 Simpson, 2014
  15q14       rs11073058     2.70E-09           Japanese/Chinese/Caucasian   Miyake, 2015
  15q14       rs524952       3.70E-06           Japanese                     Yoshikawa, 2014
  15q14       rs1370156      2.29E-07           European                     Simpson, 2014
  15q14       rs634990       p\>0.05            Chinese                      Qiang, 2014
  15q14       rs2070664      p\>0.05            Chinese                      Chen, 2015
  15q14       rs524952       1.11E-13           European/Asian               Verhoeven, 2013
  15q14       rs634990       p\>0.05            Chinese                      Chen, 2012
  15q14       rs524952       1.01E-25           European/Asian               Fan, 2016
  15q14       rs11073058     2.90E-02           Chinese                      Li, 2016
  15q14       rs2277558      p\>0.05            Chinese                      Li, 2015
  15q14       rs11073058     4.30E-11           European/Asian               Cheng, 2013
  15q14       rs634990       1.80E-03           Various                      Gong, 2016

An important and often mentioned discovery is related to two recent large-scale GWASs, which identified 24 and 22 statistically significant associations from independent cohorts. One study was a GWAS meta-analysis involving 37,382 individuals from 27 studies of European ancestry and 8,376 individuals from five Asian cohorts. The other study was a GWAS of 45,771 participants in a USA population of European ancestry. The findings are remarkable for genetic studies on myopia. These two GWASs not only replicated the previously associated loci but also identified several novel significant associations. The findings, if replicated from each other, would lead to less controversial results. There were 12 overlapping statistically significant associations with myopia and refractive error (p\<5 × 10^−8^), and the candidate genes nearby were shown as follows: protease, serine, 56 (*PRSS56*, OMIM [613858](https://www.ncbi.nlm.nih.gov/omim/?term=613858)); bone morphogenetic protein 3 (*BMP3*, OMIM [112263](https://www.ncbi.nlm.nih.gov/omim/?term=112263)); potassium voltage-gated channel, KQT-like subfamily, member 5 (*KCNQ5*, OMIM [607357](https://www.ncbi.nlm.nih.gov/omim/?term=607357)); laminin, alpha 2 (*LAMA2*, OMIM [156225](https://www.ncbi.nlm.nih.gov/omim/?term=156225)); thymocyte selection-associated high mobility group box (*TOX*, OMIM [606863](https://www.ncbi.nlm.nih.gov/omim/?term=606863)); tight junction protein 2 (*TJP2*, OMIM [607709](https://www.ncbi.nlm.nih.gov/omim/?term=607709)); retinol dehydrogenase 5 (11-cis/9-cis; *RDH5*, OMIM [601617](https://www.ncbi.nlm.nih.gov/omim/?term=601617)); zinc family member 2 (*ZIC2*, OMIM [603073](https://www.ncbi.nlm.nih.gov/omim/?term=603073)); Ras protein-specific guanine nucleotide-releasing factor 1 (*RASGRF1*, OMIM [606600](https://www.ncbi.nlm.nih.gov/omim/?term=606600)); *GJD2*; RNA binding protein, fo×-1 homolog (*C. elegans*) *1* (*RBFOX1*, OMIM [605104](https://www.ncbi.nlm.nih.gov/omim/?term=605104)); and *shisa family member 6* (*SHISA6*, Gene ID 388336, OMIM [617327](https://www.ncbi.nlm.nih.gov/omim/?term=617327)). These genes are involved in neurotransmission, ion transport, retinoic acid metabolism, extracellular matrix remodeling, and eye development. They have common networks in the protein--protein interactions related to cell cycle and growth pathways, such as the well known molecular mechanisms of refractive error, which are the TGF-beta, mitogen-activated protein kinase (MAPK), and SMAD pathways. Overall, the findings of GWASs provide us with clues to discover more candidate genes and enrich our understanding of the pathogenesis of myopia.

Studies on the association of SNPs with myopia are generally based on refractive error after adjusting for age and gender. The association of SNPs with age at the onset of myopia or gender in myopia is not commonly seen but also provided us with new ideas to some extent. Association studies on SNPs with the age of myopia onset suggest that variants associated with myopia might have age-dependent genetic effects \[[@r27],[@r95]-[@r98]\]. A study of the association between the age of myopia onset and 39 previously reported associated loci among 5,200 children ages 7--15 years provided evidence \[[@r95]\]. The results categorized the variants by ages into three groups: early-onset effect remaining stable, early-onset effect progressed with increasing age, and later-onset effect. The analysis of the genetic score for the 39 loci revealed a greater percentage of variants explained the phenotype at older age (2.3% at age 15 versus 0.6% at age 7), suggesting an increased genetic effect at older age. All of this evidence implies that the effects of the associated variants on the risk of myopia vary with age. This finding provided us with the new idea that association studies should be performed in a more specific sub-phenotype \[[@r95]\], and different biologic processes might contribute to the development of myopia at different ages. The gender association of SNPs with myopia was also observed in some studies \[[@r96]-[@r99]\]. For example, an association analysis of the GSTP1 Val/Val genotype with myopia identified this genotype as having a higher frequency in female probands \[[@r96]\], the CC genotype of TGF-beta 1 gene polymorphism (T869C) was statistically significantly associated with low myopia cases among male probands \[[@r97]\], and the DN genotype in endostatin gene polymorphism (D104N) increased the risk of myopia for women \[[@r98]\]. This evidence provided the information that gender is an important factor affecting the results and should be controlled in association analyses.

### 3.2.2 Identification of susceptibility loci for high myopia using association analysis

GWASs and case-control studies have tested at least 27 loci associated with non-syndromic high myopia based on a refraction of SEM \< −6.00 D (Appendix 2) \[[@r16],[@r29],[@r44]-[@r48],[@r50],[@r63],[@r64],[@r66],[@r68],[@r72],[@r75],[@r99]-[@r178]\]. Of these studies, eight loci were identified by GWASs and GWAS meta-analyses in Chinese, French, and Japanese populations and met the requirement of p\<5 × 10^−8^ (Appendix 2). These loci were 2q22.3, the best SNP ([rs13382811](https://www.ncbi.nlm.nih.gov/snp/?term=rs13382811)) near the *ZFHX1B* (Gene ID 9839, OMIM [605802](https://www.ncbi.nlm.nih.gov/omim/?term=605802)) gene; 4q25 (*MYP11*), the best SNP ([rs10034228](https://www.ncbi.nlm.nih.gov/snp/?term=rs10034228)); 7p36.3 (*MYP4*), the best SNP ([rs2730260](https://www.ncbi.nlm.nih.gov/snp/?term=rs2730260)) near the *VIPR2* (Gene ID 7434, OMIM [601970](https://www.ncbi.nlm.nih.gov/omim/?term=601970)) gene; 8q24.12, the best SNP ([rs4455882](https://www.ncbi.nlm.nih.gov/snp/?term=rs4455882)) near the *SNTB1* (Gene ID 6641, OMIM [600026](https://www.ncbi.nlm.nih.gov/omim/?term=600026)) gene; 8q23 (*MYP10*), the best SNP ([rs17155227](https://www.ncbi.nlm.nih.gov/snp/?term=rs17155227)) near the *MIR4660* (Gene ID 100616350) and *PPP1R3B* (Gene ID 79660, OMIM [610541](https://www.ncbi.nlm.nih.gov/omim/?term=610541)) genes; 13q12.12 (*MYP20*), the best SNP ([rs9318086](https://www.ncbi.nlm.nih.gov/snp/?term=rs9318086)) near the *MIPEP* (Gene ID 4285, OMIM [602241](https://www.ncbi.nlm.nih.gov/omim/?term=602241)), *C1QTNF9B-AS1* (Gene ID 542767, OMIM [617122](https://www.ncbi.nlm.nih.gov/omim/?term=617122)), and *C1QTNF9B* (Gene ID 387911, OMIM [614148](https://www.ncbi.nlm.nih.gov/omim/?term=614148)) genes; 15q14, the best SNP ([rs11073058](https://www.ncbi.nlm.nih.gov/snp/?term=rs11073058)) near the *GJD2* gene; and 22q13.31, the best SNP ([rs10453441](https://www.ncbi.nlm.nih.gov/snp/?term=rs10453441)) near the *WNT7B* (Gene ID 7477, OMIM [601967](https://www.ncbi.nlm.nih.gov/omim/?term=601967)) gene. Some were consistent with the findings in linkage studies, as seen in 7p36.3 (*MYP4*), 4q25 (*MYP11*), 13q12.12 (*MYP20*), and 8q23 (*MYP10*).

The SNP rs4455882 near *SNTB1* has been reported to be statistically significantly associated with high myopia in a Chinese population and reached a best p value of 2.13 × 10^−11^ using GWAS meta-analysis (665 high myopia cases and 960 controls) followed by replications in three additional cohorts (a total of 2,128 cases and 3,683 controls) \[[@r154]\]. Another SNP, [rs6469937](https://www.ncbi.nlm.nih.gov/snp/?term=rs6469937) in *SNTB1*, was also found to be statistically significantly associated with myopia in another meta-analysis study \[[@r179]\]. *SNTB1* is expressed in the human retina and sclera \[[@r179]\]. In mice with induced myopia, the expression of *SNTB1* was downregulated in the retina/RPE compared with that in control mice \[[@r179]\]. This line of evidence indicates that *SNTB1* might be the best candidate gene for high myopia as suggested by GWASs. Other loci were less replicated or replicated in controversial studies. None of the causative variants were detected in the myopia-associated genes.

### 3.2.3 Association studies of quantitative trait analysis

Axial length and corneal curvature are key determinants of the refractive power in the eye. Association studies on these quantitative traits have tested 21 susceptible loci for ocular axial length and corneal curvature ([Table 4](#t4){ref-type="table"}) \[[@r3],[@r69],[@r79],[@r80],[@r141],[@r180]-[@r184]\]. Of these loci, 16 were identified as statistically significantly associated with phenotype by GWASs, reaching p\<5 × 10^−8^.

###### Loci or genes tested in association with quantitative trait analysis.

  **CHR**   **Loci/Location**   **Gene**   **Method**   **Population**               **Best SNP**   **Best p value**   **First author, year**
  --------- ------------------- ---------- ------------ ---------------------------- -------------- ------------------ ------------------------
  1         1q32.2              CD55       GWAS-Meta    European/Asian               CD55           2.30E-07           Cheng, 2013
  1         1p33                CMPK1      GWAS-Meta    Asian                        rs17103186     3.30E-12           Chen, 2014
  1         1p36.2              FRAP1      GWAS         European                     NO             p\>0.05            Guggenheim, 2013
  1         1p36.2              FRAP1      Meta         Australian                   NO             p\>0.05            Mishra, 2012
  1         1p36.22             MTOR       GWAS-Meta    Asian                        rs74225573     4.00E-13           Chen, 2014
  1         1p34.3              RSPO1      GWAS-Meta    European/Asian               rs4074961      9.60E-13           Cheng, 2013
  1         1q41                ZC3H11B    GWAS-Meta    European/Asian               rs994767       9.60E-12           Cheng, 2013
  2         2q37.1              ALPPL2     GWAS-Meta    European/Asian               ALPPL2         1.80E-06           Cheng, 2013
  3         3q12.1              C3orf26    GWAS-Meta    European/Asian               rs9811920      4.90E-11           Cheng, 2013
  4         4q12                PDGFRA     GWAS         European                     rs6554163      2.80E-06           Guggenheim, 2013
  4         4q12                PDGFRA     GWAS-Meta    Asian                        rs1800813      3.30E-10           Chen, 2014
  4         4q12                PDGFRA     Meta         Australian                   rs2114039      4.50E-03           Mishra, 2012
  4         4q12                PDGFRA     GWAS         Chinese and Malay            rs7677751      7.87E-09           Fan, 2011
  6         MYP2/6q22.33        LAMA2      GWAS-Meta    European/Asian               rs12193446     1.20E-08           Cheng, 2013
  7         7q21.11             HGF        A            Chinese                      rs3735520      5.00E-02           Chen, 2012
  7         7q31.2              MET        A            Caucasian                    NO             p\>0.05            Schache, 2009
  10        10q11.22            RBP3       GWAS-Meta    Asian                        rs11204213     1.10E-13           Chen, 2014
  12        12q23.2             IGF1       A            Chinese                      rs6214         3.40E-02           Chen, 2012
  12        12q13.3             MIP        GWAS-Meta    European/Asian               MIP            2.80E-07           Cheng, 2013
  15        15q14               GJD2       GWAS         Japanese/Chinese/Caucasian   rs11073058     2.70E-09           Miyake, 2015
  15        15q14               GJD2       A            Chinese                      rs634990       p\>0.05            Chen, 2012
  15        15q14               GJD2       GWAS-Meta    European/Asian               rs11073058     4.30E-11           Cheng, 2013
  15        15q14               NA         A            Caucasian                    rs560764       6.40E-04           Schache, 2013
  15        15q25               NA         A            Caucasian                    NO             p\>0.05            Schache, 2013
  18        MYP2/18p11.31       TGIF1      A            Caucasian                    NO             p\>0.05            Pertile, 2008
  22        22q13.31            WNT7B      GWAS         Japanese/Chinese/Caucasian   rs10453441     2.90E-40           Miyake, 2015
  22        22q12.1             ZNRF3      GWAS-Meta    European/Asian               rs12321        4.10E-08           Cheng, 2013

Note: A, association; Meta, Meta-analysis; GWAS-Meta, GWAS-Meta analysis; GWAS, genome-wide association; CHR, chromosome

### 3.2.3.1 The role of axial length in association studies on myopia

In a meta-analysis of three GWASs on axial length involving 1,118 cases and 5,433 controls from Chinese and Malay populations, SNP [rs4373767](https://www.ncbi.nlm.nih.gov/snp/?term=rs4373767) in *ZC3H11B* (Gene ID 643136) was found to be statistically significantly associated with axial length (p=2.69 × 10^−10^) and high myopia (p=4.38 × 10^−7^) \[[@r185]\]. *ZC3H11B* was also replicated to be associated with axial length and high myopia in another large meta-analysis with GWASs involving a total of 12,531 Europeans and 8,216 Asians \[[@r69]\]. Together with *ZC3H11B*, six other genes, *RSPO1* (Gene ID 284654, OMIM [609595](https://www.ncbi.nlm.nih.gov/omim/?term=609595)), *C3orf26* (Gene ID 84319), *LAMA2*, *GJD2, CD55* (Gene ID 1604, OMIM [125240](https://www.ncbi.nlm.nih.gov/omim/?term=125240)), and *ZNRF3* (Gene ID 81433, OMIM [612062](https://www.ncbi.nlm.nih.gov/omim/?term=612062)), were found to be associated with axial length in this study \[[@r69]\]. The differential expression of these six genes has been observed between the induced myopic eyes and the control eyes in tissues, including the sclera, the RPE, and the neural retina. Among these genes, *GJD2* and *CD55* were previously reported to be associated with refractive error. *GJD2* is a candidate gene in the 15q14 locus, which has been replicated in multiple studies. A statistically significant SNP near *CD55* ([rs1652333](https://www.ncbi.nlm.nih.gov/snp/?term=rs1652333); p combined*=*3.05 × 10^−12^) was previously detected on a large scale in GWASs. These findings indicate that there is a close relationship between refractive error and axial length, which share about 50% of variants \[[@r186]\].

### 3.2.3.2 Association of variants with corneal curvature

GWASs in corneal curvature have identified several loci near four genes, including *PDGFRA* (Gene ID 5156, OMIM [173490](https://www.ncbi.nlm.nih.gov/omim/?term=173490); 4p12), *CMPK1* (Gene ID 51727, OMIM [191710](https://www.ncbi.nlm.nih.gov/omim/?term=191710); 1p32), *RBP3* (Gene ID 5949, OMIM [180290](https://www.ncbi.nlm.nih.gov/omim/?term=180290); 10q11.2), and *FRAP1* (Gene ID 2475, OMIM [601231](https://www.ncbi.nlm.nih.gov/omim/?term=601231); 1p36.2), that are statistically significantly associated with corneal curvature. *FRAP1* and *PDGFRA* were first identified in a GWAS in an Asian population from Singapore and were replicated in two subsequent GWASs. Together with *FRAP1* and *PDGFRA*, one of the subsequent GWAS discovered two other novel genes, *CMPK1* and *RBP3*, associated with corneal curvature. These studies have opened a new path for investigating the molecular genetic basis of myopia, although the relationship between myopia and the genes associated with corneal curvature is unclear. Thus, it might be of interest for further study in the future.

### 3.2.4 Association studies on myopia: Principles and directions for the future

More myopia loci have been identified by GWASs, but these loci account for a small proportion (less than 1%) of myopia in the general population. All of these significant associations tend to have a small effect due to their high allele frequencies. Thus, genotyping genomic regions near the significant locus in a larger cohort might detect variants with very rare frequencies and high penetrance, as seen in the discovery of highly penetrant variants in the *CFH* (Gene ID 3075, OMIM [134370](https://www.ncbi.nlm.nih.gov/omim/?term=134370)) gene associated with age-related macular degeneration. Our previous study of 12 myopia-associated genes identified several rare variants in families with high myopia using whole exome sequencing \[[@r122]\]. Although the variant types and allele frequencies did not show statistically significant differences between the cases and controls, it opened up a new approach to analyze significant associations implicated by GWASs.

Most of the significant associations are located outside the protein-coding regions. Genes close to the significant regions are considered potential causative genes and chosen for further study. Even though no mutations in candidate genes have been identified, systemically reviewing genes near significant regions can enrich our understanding of pathways and gene--gene networks in the development of myopia.

In summary, all SNPs related to myopia, high myopia, axial length, and corneal curvature have been summarized according to their positions in the chromosome. SNPs identified by GWASs must be consistent with the principle of replication and reach the significant association level of p≤5 × 10^−8^. Recruiting larger cohorts or conducting an international collaboration would be helpful to improve statistical power and enable the discovery of additional significant associations.

### 3.3 Unraveling causative genes for high myopia with whole exome sequencing

Whole exome sequencing has been widely used in studies on genetic defects for high myopia. With exome sequencing, ten genes in total have thus far been reported as associated with high myopia ([Table 5](#t5){ref-type="table"}), including four genes related to AD high myopia (*ZNF644*: Gene ID 84146, OMIM [614159](https://www.ncbi.nlm.nih.gov/omim/?term=614159), *SLC39A5*: Gene ID 283375, OMIM [608730](https://www.ncbi.nlm.nih.gov/omim/?term=608730), *SCO2*: Gene ID 9997, OMIM [604272](https://www.ncbi.nlm.nih.gov/omim/?term=604272), *P4HA2*: Gene ID 8974, OMIM [600608](https://www.ncbi.nlm.nih.gov/omim/?term=600608)), three genes related to AR high myopia (*LRPAP1*: Gene ID 4043, OMIM [104225](https://www.ncbi.nlm.nih.gov/omim/?term=104225), *LEPREL1*: Gene ID 55214, OMIM [610341](https://www.ncbi.nlm.nih.gov/omim/?term=610341), *CTSH*: Gene ID 1512, OMIM [116820](https://www.ncbi.nlm.nih.gov/omim/?term=116820)), two genes for XL high myopia (*OPN1LW*: Gene ID 5956, OMIM [300822](https://www.ncbi.nlm.nih.gov/omim/?term=300822) and *ARR3*: Gene ID 407, OMIM [301770](https://www.ncbi.nlm.nih.gov/omim/?term=301770)), and one gene (*BSG*: Gene ID 682, OMIM [109480](https://www.ncbi.nlm.nih.gov/omim/?term=109480)) inherited by de novo mutations \[[@r68],[@r187]-[@r199]\].

###### Genes suggested from exome sequencing studies.

  **Inheritance**   **Locus**   **Region**   **Gene**   **Mutation**      **Reference**
  ----------------- ----------- ------------ ---------- ----------------- ----------------------------------------
  AD                MYP21       1p22.2       ZNF644     p.S672G           (Shi et al., 2011; Jiang et al., 2014)
  AD                MYP21       1p22.2       ZNF644     p.R680G           (Shi et al., 2011)
  AD                MYP21       1p22.2       ZNF644     p.C699Y           (Shi et al., 2011)
  AD                MYP21       1p22.2       ZNF644     p.T242M           (Tran-Viet et al., 2012)
  AD                MYP21       1p22.2       ZNF644     p.E274V           (Tran-Viet et al., 2012)
  AD                MYP21       1p22.2       ZNF644     p.T401A           (Xiang et al., 2014)
  AD                MYP21       1p22.2       ZNF644     p.E1278G          (Xiang et al., 2014)
  AD                MYP21       1p22.2       ZNF644     p.R683T           (Jiang et al., 2014)
  AD                MYP21       1p22.2       ZNF644     p.D851H           (Jiang et al., 2014)
  AD                MYP25       5q31.1       P4HA2      p.E291K           (Guo et al., 2015)
  AD                MYP25       5q31.1       P4HA2      p.K443\*          (Guo et al., 2015)
  AD                MYP25       5q31.1       P4HA2      p.Q140R           (Guo et al., 2015)
  AD                MYP25       5q31.1       P4HA2      p.I150V           (Guo et al., 2015)
  AD                MYP25       5q31.1       P4HA2      p.R451Gfs\*8      (Guo et al., 2015)
  AD                MYP24       12q13.3      SLC39A5    p.Y47\*           (Guo et al., 2015)
  AD                MYP24       12q13.3      SLC39A5    p.M304T           (Guo et al., 2015)
  AD                MYP24       12q13.3      SLC39A5    p.G413A           (Jiang et al., 2014)
  AD                Unknown     22q13.33     SCO2       p.R112W           (Jiang et al., 2014)
  AD                Unknown     22q13.33     SCO2       p.R120W           (Jiang et al., 2014)
  AD                Unknown     22q13.33     SCO2       p.Q53\*           (Yanovitch et al., 2013)
  AD                Unknown     22q13.33     SCO2       p.R114H           (Yanovitch et al., 2013)
  AD                Unknown     22q13.33     SCO2       p.E140K           (Yanovitch et al., 2013)
  AD                Unknown     22q13.33     SCO2       p.A259V           (Yanovitch et al., 2013)
  AR                Unknown     3q28         LEPREL1    p.G508V           (Mordechai et al., 2011)
  AR                Unknown     3q28         LEPREL1    p.Q5\*            (Guo et al., 2014)
  AR                MYP23       4p16.3       LRPAP1     p.N202Tfs∗8       (Aldahmesh et al., 2013)
  AR                MYP23       4p16.3       LRPAP1     p.I288Rfs∗118     (Aldahmesh et al., 2013)
  AR                MYP23       4p16.3       LRPAP1     p.Q67Sfs\*8       (Jiang et al., 2014)
  AR                MYP23       15q25.1      CTSH       p.L162Pfs\*66     (Aldahmesh et al., 2013)
  X-linked          MYP1        Xq28         OPN1LW     LVAVA haplotype   (Li et al., 2015)
  X-linked          Unknown     Xq13.1       ARR3       p.L80P            (Xiao et al., 2016)
  X-linked          Unknown     Xq13.1       ARR3       p.R100\*          (Xiao et al., 2016)
  X-linked          Unknown     Xq13.1       ARR3       p.A298D           (Xiao et al., 2016)
  De Novo           Unknown     19p13.3      BSG        p.G297S           (Jin et al., 2017)
  De Novo           Unknown     19p13.3      BSG        p.P221S           (Jin et al., 2017)
  De Novo           Unknown     19p13.3      BSG        p.Q69X            (Jin et al., 2017)
  De Novo           Unknown     19p13.3      BSG        pc.415+1G\>A      (Jin et al., 2017)

Among these genes, mutations detected in genes with the AD trait were mostly missense, while those in genes with AR were mainly frameshift mutations. All of these genes are common in the expression spectrum in eye tissues, including the sclera, retina, and RPE; these genes also have a close relationship with the mechanism underlying the development of myopia. *LRPAP1* and *SCL39A5* were identified to be involved in the well known pathway TGF-beta/BMP. The mice that were homozygous deficient in *LRPAP1* had reduced expression of *LRP* in the liver and brain \[[@r200]\], which, in turn, caused the activation of TGF-beta \[[@r201]\]. *LRPAP1* was assumed to be associated with myopia through regulating the expression of TGF-beta. A loss of function in *SLC39A5* was detected as involved in the expression of Smad1, a key phosphate protein downstream of the TGF-beta/BMPs. Other genes were involved with collagen synthesis (*LERPEL1*), ATP metabolism in the retina (*SCO2*), the transcription factor (*ZNF644*), and the degradation of lysosomal proteins (*CTSH*). The exact mechanisms of these genes remain unclear, and functional studies are anticipated in the future.

A recent analysis of whole exome sequencing data from 298 probands with early-onset high myopia discovered that one-fourth of the probands carried mutations in the genes responsible for retinal diseases and myopia-related syndromes \[[@r202]\]. This finding provided further clues for candidate gene screening using whole exome sequencing. Overall, in the era of whole exome sequencing, more genes are expected to be identified, which will provide more information on mechanisms of high myopia.

### 3.4 Gene analysis in the experimental animal models of myopia

Animal models of myopia are used to identify the altered expression of genes in the retina, RPE, choroid, and sclera or to observe the features of myopia after knocking out the targeted gene. Methods for establishing myopia models include the form deprivation myopia (FDM), lens-induced myopia (LIM), and knockout animal models. The animal models are varied and can include chicks, mice, guinea pigs, rabbits, monkeys, or tree shrews, as well as the recently used zebrafish.

Experimental studies on myopia have provided convincing evidence for the role of the RPE, choroid, and sclera in the regulation of ocular growth and the development of myopia \[[@r203]-[@r212]\]. Animal models established by FDM and LIM have been widely used to investigate the candidate genetic factors underlying ocular growth and myopia. Studies on RPE have revealed that BMPs (typically *BMP2*: Gene ID 650, OMIM [112261](https://www.ncbi.nlm.nih.gov/omim/?term=112261), *BMP4*: Gene ID 652, OMIM [112262](https://www.ncbi.nlm.nih.gov/omim/?term=112262), *BMP7*: Gene ID 655, OMIM [112267](https://www.ncbi.nlm.nih.gov/omim/?term=112267)) have bidirectional regulation during ocular growth \[[@r203],[@r211]\]. For example, the expression of *BMP2* was upregulated in a myopic defocus model (induced hyperopia) and downregulated in a hyperopic defocus model (induced myopia) \[[@r203]\]. BMPs encode secreted ligands of the TGF-beta superfamily of proteins involved in the TGF-beta/BMPs pathway. The expression of TGF-beta isoforms (TGF-beta 1, 2, and 3) in chick RPE was also found to be statistically significantly different in the LIM chick model \[[@r213]\]. All of this evidence indicates that TGF-beta superfamily members are involved in the regulation of ocular growth and suggests that the RPE plays a role as a signal relay. Studies on the choroid indicated its active role in conveying signals from the retina to the sclera \[[@r210]\]. Significant differences in gene expression in the choroid were observed between eyes with induced myopia and control eyes \[[@r205],[@r206],[@r210],[@r213]\]. In addition, it is well accepted that the sclera plays a pivotal role in controlling ocular size. Sclera remodeling leads to decreased collage synthesis, scleral thinning, and loss of scleral tissue, all of which underlie the development of myopia \[[@r214]\].Thus, the alteration of scleral gene expression during the development and recovery of induced myopia in animal models has been widely investigated to explore the relationship between candidate genes and myopia \[[@r204],[@r207],[@r208],[@r215]-[@r223]\]. Genes involved in scleral remodeling, such as *TGF-beta isoforms*, *BMPs*, *cAMP*: Gene ID 820, OMIM [600474](https://www.ncbi.nlm.nih.gov/omim/?term=600474), *COL1A1*: Gene ID 1277, OMIM [120150](https://www.ncbi.nlm.nih.gov/omim/?term=120150), *TIMPs*, and *GAGs*, were investigated mostly based on their functions as ocular growth factors, extracellular matrix (ECM) protein and enzymes, and their role in ECM and collagen synthesis. However, no specific mutations were detected among these genes associated with myopia in human beings. Most alterations in gene expression tend to be consistent during the development and recovery of induced myopia. This evidence not only indicates that scleral remodeling might involve the modulation of gene expression at the transcriptional level but also suggests that scleral remodeling is too complex to be explained by a single gene.

The genes identified in experimental myopia studies have features in common. First, they have expression in the sclera, retina, or choroid. Second, increased or decreased changes in expression can be observed in induced myopia models. Third, knockout animal models present with some related features of myopia, such as a thinner sclera, an elongated axial length, and the decreased synthesis of collagen fibers. Importantly, most of these genes are relevant to the signaling pathways possibly underlying myopia ([Table 6](#t6){ref-type="table"}) \[[@r121],[@r203]-[@r207],[@r211],[@r217],[@r224]-[@r246]\], although most have yet to be determined. The potential signaling pathways are TGF-beta signaling, scleral remodeling, Wnt signaling, Pax6 in early embryonic growth, Sonic hedgehog, retinoic acid, nitric oxide synthase, neurotransmitter, muscarinic receptor signaling, and retinal dopamine signaling. Among them, the well recognized signaling pathway is the TGF-beta/BMPs pathway, which has been implicated independently in different studies. The TGF-beta/BMPs pathway is considered to have a potential role in controlling ocular growth. Decreased expression of TGF-beta isoforms (the TGF-beta 1 to 3 isoforms) in the sclera of the FDM animal models was intended to reduce the synthesis of collagen, thus making a contribution to the sclera remodeling in the myopic eye. Additional candidate genes related to the TGF-beta/BMPs pathway will be of interest for future investigation.

###### Genes analyzed in experimental myopia studies.

  Potential pathway                             Gene involved in animal models                                                                                  Function related with myopia                    Refs.
  --------------------------------------------- --------------------------------------------------------------------------------------------------------------- ----------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Environmental induced animal model studies:                                                                                                                                                                   
  TGF-beta                                      TGF-beta 1--3, Zfhx1b, BMP2, BMP4, BMP5, and BMP7                                                               Ocular growth                                   Jobling et al. (2004); Jobling et al. (2009); Mathis et al. (2010); Khor et al.(2013); Zhang et al. (2012); Zhang et al. (2013); Zhang et al. (2016); Wang et al. (2011); Li et al. (2015)
  Scleral remodeling                            GAGs, MMPs, TIMPs, BMP2, and TGF-β                                                                              Scleral remodeling                              Mcbrien et al. (2000); Siegwart et al.(2005); Li et al.(2015)
  Wnt signaling                                 Wnt2b, Fzd5, and β-catenin                                                                                      Ocular growth                                   Ma et al.(2014)
  Pax-6                                         Pax-6                                                                                                           Early embryonic growth                          Bhat et al.(2004); Ashby et al. (2009); Zhong et al.(2004)
  Sonic hedgehog                                Shh                                                                                                             Ocular growth                                   Akamatsu et al.(2001); Escaño et al.(2000); Qian et al.(2009)
  Retinoic acid receptor                        Retinoic acid receptor                                                                                          Ocular growth                                   Seko et al. (1996); Morgan et al.(2004); Wang et al.(2014)
  Nitric oxide synthase                         NOS isoform (iNOS, eNOS bNOS)                                                                                   Nitric oxide synthase                           Fujii et al. (1998)
  Neurotransmitter/neuromodulator               Glucagon and its receptors                                                                                      Increased the Camp                              Feldkaemper et al. (2000);Feldkaemper et al.(2004)
  Muscarinic receptor signaling                 Muscarinic subtypes M1 to M5                                                                                    Ocular growth                                   Liu et al. (2007)
  Retinal dopamine                              D2R                                                                                                             Light adaptation and retinal circadian rhythm   Huang et al. (2014)
  Cell surface                                  EPHA1, SCUBE3, P2RY1, VIPR2, and NPR3                                                                           Ocular growth regulation                        He et al. (2014) ; Lin et al. (2013)
  Cytoskeleton related                          ANXA2, CAPNS1, and NGEF                                                                                         Axial elongation                                Lin et al. (2013)
  Intracellular signaling                       BCO2, ZNF185, CYP26B1, RLBP1, and RPE65                                                                         Ocular growth regulation                        He et al. (2014)
  Transcription signaling                       HIF1A and EGR1                                                                                                  Ocular growth regulation                        He et al. (2014)
  Secreted signaling                            IGF2, NRG1, PT15, FAM180A, MEST, SOSTDC1,TGFBI, CILP, PENK, PTX3, ANGPTL7, BMP2, BMP4, TGFB2, TGFB3, and IL18   Ocular growth regulation                        He et al. (2014) ; Lin et al. (2013)
  Matricellular signaling                       NOV, THBS1, CYR61, CTGF,and TNC                                                                                 Ocular growth regulation                        He et al. (2014) ; Lin et al. (2013)
  MPs/TIMPs signaling                           ADAMTSL3, TIMP1, TIMP3, ADAMTS5, and MMP14                                                                      Ocular growth regulation                        He et al. (2014) ; Lin et al. (2013)
  Extracellular matrix                          COL6A6, COL12A1, OGN, MXRA5, and NYX                                                                            Ocular growth regulation                        He et al. (2014)
  Genetic induced animal model studies                                                                                                                                                                          
  Collagen synthesis                            P3h2                                                                                                            Related with the collagen synthesis in sclera   Hudson et al. (2015)
  Soni hedgehog                                 Lrp2                                                                                                            An endocytic receptor                           Veth et al.(2011); Collery et al.(2014)
  Transcriptional regulatory                    Egr-1                                                                                                           A transcription factor                          Schippert et al. (2007)

In addition, animal model studies have provided further evidence to support the findings of association studies, whole exome sequencing, and linkage studies. In human beings, P3H2 is encoded by *LERPEL1*, in which mutations have been reported to be associated with autosomal recessive high myopia using whole exome sequencing \[[@r192]\]. *P3h2* null mice were further observed with altered collagen prolyl 3-hydroxylation \[[@r235]\], which is believed to cause abnormalities in the structure of the sclera, thus resulting in progressive myopia. A GWAS identified *ZFHX1B* as a susceptible locus for severe myopia \[[@r121]\]. The decreased expression of *Zfhx1b* was observed from the induced experimental mouse model for myopia, providing further evidence of the involvement of this locus in the development of myopia \[[@r121]\]. However, we still have little knowledge about the exact relationship between induced myopia in animals and physiologic myopia in humans, and the exact variants in most of the genes suggested by animal studies are still unclear.

4. Molecular genetic basis of syndromic high myopia
---------------------------------------------------

Myopia, usually high myopia, has been reported as a feature in a variety of ocular and systemic syndromes. These myopic syndromes are often shown in Mendelian inheritance patterns, and the genetic defects underlying these syndromes have been well clarified with certain protein-coding genes. A total of 382 entries were obtained using "myopia" as a search word (until 3/18/2017) in [OMIM](https://www.ncbi.nlm.nih.gov/omim/). Entries associated with syndromic myopia were included and reviewed. A total of 115 genes were identified as the causes of the 131 syndromes accompanied by myopia (Appendix 3) \[[@r116],[@r164],[@r192],[@r247]-[@r416]\]. These syndromes shown in Appendix 3 are congenital and inherited by defects in certain genes in a pattern of autosomal recessive, autosomal dominant, or X-linked inheritance.

Myopic syndromes have variable clinical manifestations, ranging from mild to severe, that affect patients' daily lives in various aspects. Some even lead to death after birth or in childhood. Myopia or high myopia is one of these variable features, and other clinical features involve many different systems, especially other segments of the ocular system, nervous system, or locomotor system. For example, some ocular abnormalities include astigmatism, nystagmus, night blindness, strabismus, microphthalmia, microcornea, brittle cornea, keratoconus, cataract, ectopia lentis, posterior staphyloma, glaucoma, vitreoretinopathy, retinitis pigmentosa, and retinal detachment. In association with the nervous system, mental retardation, microcephaly, cerebellar hypoplasia, special facial appearance, and hearing loss are often seen. In ophthalmology, myopic syndromes, such as Stickler syndrome, Marfan syndrome, congenital stable night blindness (CSNB), retinitis pigmentosa (RP) associated with *RP2* (Gene ID 6102, OMIM [312600](https://www.ncbi.nlm.nih.gov/omim/?term=312600)) and *RPGR* (Gene ID 6103, OMIM [312610](https://www.ncbi.nlm.nih.gov/omim/?term=312610)), Bornholm eye disease (BED), and cone-rod dystrophy (CORD), have been well established, and high myopia is their common feature. Others involving primarily non-ocular systems are rare and have not been thoroughly investigated.

Systematic reviews of myopia-related syndromes have great implications in diagnosis, prevention, and treatment. Two studies \[[@r417],[@r418]\] revealed that most patients diagnosed with simple myopia showed other ocular or systemic symptoms after full assessment, especially children under 10 years of age. Stickler syndrome, Marfan syndrome, and retinal dystrophy were predominantly seen. If early diagnosis and early prevention were made available for patients with conditions such as Stickler syndrome, it would reduce their chances of developing retinal detachment using prophylactic cryotherapy. Practically, high myopia might be an earlier feature in some syndromes or a major complaint in a patient\'s first visit. In routine clinical practice, syndromic high myopia was generally considered to be rare and might be simply cosidered as high myopia alone due to unawareness or atypical manifestation of other major signs. This situation may not well recorgnized until recently. Sun et al. performed a systematic analysis of the genes associated with retinal dystrophy and myopia-related syndromes in 298 probands with early-onset high myopia (eoHM) \[[@r202]\]. Mutations were identified in one-fourth of the probands, of whom 62% have mutations in the genes that contribute to myopia-related syndromes. Mutations in genes *COL2A1* (Gene ID 1280, OMIM [120140](https://www.ncbi.nlm.nih.gov/omim/?term=120140)) and *COL11A1* (Gene ID 1301, OMIM [120280](https://www.ncbi.nlm.nih.gov/omim/?term=120280)) associated with Stickler syndrome, *CACNA1F* (Gene ID 778, OMIM [300110](https://www.ncbi.nlm.nih.gov/omim/?term=300110)) associated with CSNB, and *RPGR* associated with XL-RP were predominantly discovered among these probands. Follow-up examination on some of the eoHM with the mutations revealed that: 1) some of the eoHM are still hardly recorgnized as related syndromes due to atypical or variable manifestation, and 2) a small portion of those eoHM should be syndromic high myopia if systemic examination of the eyes as well as other related organs could be thoroughly performed. The investigation of the genes associated with syndromic high myopia has also become an additional approach for the candidate gene screening of isolated high myopia based on a common molecular genetic function, such as involving the ECM and connective tissues. Mutations in *NYX* (Gene ID 60506, OMIM [300278](https://www.ncbi.nlm.nih.gov/omim/?term=300278)) have been reported to cause high myopia without congenital stationary night blindness (CSNB1) \[[@r419]\]. A recent study conducted with seven families with BED, two of whom were previously mapped to the *MYP1* locus, discovered two rare haplotypes (*LIAVA* and *LVAVA*) underlying BED \[[@r334]\]. Li et al. later found that one of the haplotypes (LVAVA) also contributes to two large families with X-linked non-syndromic high myopia \[[@r191]\]. These observations suggest that there is a close relationship between the genetic basis for syndromic and non-syndromic high myopia, and thus, it is a good approach for investigating the genes implicated in studies of syndromic high myopia.

5. Conclusions
--------------

This review provides a comprehensive overview of studies on the molecular genetics of myopia. For the reported genetics factors associated with myopia listed in this review, some might be very preliminary while a few may already have contradictory evidence. Therefore, many of the myopia-related genes or loci need to be further validated. In addition, for most loci or associated SNPs, the exact genetic defects and their related functional consequence that contributes to myopia await disclosure. No specific pathways underlying myopia have been clarified that would impede our prioritization of candidate genes. Therefore, in conjunction with functional studies and a combination of different technologies will be helpful for enhancing our understanding of the genetic factors in myopia, ultimately leading to improvements in the prediction of onset, prevention, and treatment in the future.

The authors acknowledge the grant support from the Natural Science Foundation of Guangdong (S2013030012978), the National Natural Science Foundation of China (81770965), the Science and Technology Planning Projects of Guangzhou (201607020013), and the Fundamental Research Funds of the State Key Laboratory of Ophthalmology

AL, axial length; CC, corneal curvature, CHR, chromosome; A, association analysis; GWAS, genome-wide association study; SPE, spherical equivalent; NA, not available; GWAS-Meta: Genome-wide meta analysis. To access the data, click or select the words "[Appendix 1](http://www.molvis.org/molvis/v23/appendices/mv-v23-1048-app-1.docx)"

Note: CHR, chromosome; A, association study; AL, axial length, CC, Corneal curvature; GWAS, genome-wide association study;Meta: Meta analysis; NA, not available. To access the data, click or select the words "[Appendix 2](http://www.molvis.org/molvis/v23/appendices/mv-v23-1048-app-2.docx)"

Note: IC, isolated cases; AR, autosomal recessive; AD, autosomal domiant; NA, non-available; \#, References only included the first published paper for clinical features report and genetic analysis. To access the data, click or select the words "[Appendix 3](http://www.molvis.org/molvis/v23/appendices/mv-v23-1048-app-3.docx)"
